Abstract
In this review, we describe neuropsychological and brain imaging findings in the early stages of psychosis and schizophrenia. We focus on recent clinical high-risk studies and consider whether the evidence supports these as ‘endophenotypes’ of a vulnerability to the illness or as ‘biomarkers’ of illness onset and transition. The findings suggest that there are a number of processes at psychosis onset that may represent biomarkers of incipient illness. These neurobiological indices particularly implicate the integrity of frontal and temporal cortices, which may or may not be related to the genetics of psychosis (i.e. potential ‘endophenotypes’). However, these brain regions are dynamically changing during normal maturation, meaning that any putative neurobiological markers identified at the earliest stages of illness may be relatively unstable. We suggest that, while such measures may be readily identified as potential neurobiological markers of established illness, they are inconsistent at (or around) the time of illness onset when assessed cross-sectionally. Instead, identification of more valid risk markers may require longitudinal assessment to ascertain normal or abnormal trajectories of neurodevelopment. Accordingly, we assert that the current conceptualisations of potential biomarkers and/or ‘endophenotypes’ for schizophrenia may need to be reconsidered in the context of normal and abnormal brain maturational processes at the time of onset of psychotic disorders.
Similar content being viewed by others
References
Asato, M. R., Sweeney, J. A., & Luna, B. (2006). Cognitive processes in the development of TOL performance. Neuropsychologia, 44(12), 2259–2269.
Bartok, E., Berecz, R., Glaub, T., & Degrell, I. (2005). Cognitive functions in prepsychotic patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 29(4), 621–625.
Benetti, S., Mechelli, A., Picchioni, M., Broome, M., Williams, S., and McGuire, P. (2009). Functional integration between the posterior hippocampus and prefrontal cortex is impaired in both first episode schizophrenia and the at risk mental state. Brain.
Berger, G. E., Wood, S. J., Pantelis, C., Velakoulis, D., Wellard, R. M., & McGorry, P. D. (2002). Implications of lipid biology for the pathogenesis of schizophrenia. Australian and New Zealand Journal of Psychiatry, 36(3), 355–366.
Berger, G. E., Wood, S. J., Velakoulis, D., Ang, A., Brewer, W. J., Phillips, L. J., et al. (2007). Ventricle volumes in emerging psychosis. A cross-sectional and longitudinal MR1 study. European Psychiatry, 22, S30–S31.
Bertolino, A., Callicott, J. H., Elman, I., Mattay, V. S., Tedeschi, G., Frank, J. A., et al. (1998). Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study. Biological Psychiatry, 43(9), 641–648.
Bora, E., Yucel, M., Fornito, A., Berk, M., & Pantelis, C. (2008). Major psychoses with mixed psychotic and mood symptoms: are mixed psychoses associated with different neurobiological markers? Acta Psychiatrica Scandinavica, 118(3), 172–187.
Borgwardt, S. J., Riecher-Rossler, A., Dazzan, P., Chitnis, X., Aston, J., Drewe, M., et al. (2007). Regional gray matter volume abnormalities in the at risk mental state. Biological Psychiatry, 61(10), 1148–1156.
Borgwardt, S. J., McGuire, P. K., Aston, J., Gschwandtner, U., Pfluger, M. O., Stieglitz, R. D., et al. (2008). Reductions in frontal, temporal and parietal volume associated with the onset of psychosis. Schizophrenia Research, 106(2–3), 108–114.
Braff, D. L., Freedman, R., Schork, N. J., & Gottesman, I. I. (2007). Deconstructing schizophrenia: an overview of the use of endophenotypes in order to understand a complex disorder. Schizophrenia Bulletin, 33(1), 21–32.
Brewer, W. J., Wood, S. J., McGorry, P. D., Francey, S. M., Phillips, L. J., Yung, A. R., et al. (2003). Impairment of olfactory identification ability in individuals at ultra-high risk for psychosis who later develop schizophrenia. American Journal of Psychiatry, 160(10), 1790–1794.
Brewer, W. J., Francey, S. M., Wood, S. J., Jackson, H. J., Pantelis, C., Phillips, L. J., et al. (2005). Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis. American Journal of Psychiatry, 162(1), 71–78.
Brewer, W. J., Pantelis, C., De Luca, C. R., & Wood, S. J. (2006). Olfactory processing and brain maturation. In W. J. Brewer, D. J. Castle & C. Pantelis (Eds.), Olfaction and the brain (pp. 103–118). Cambridge: Cambridge University Press.
Brewer, W. J., Yucel, M., Harrison, B. J., McGorry, P. D., Olver, J., Egan, G. F., et al. (2007). Increased prefrontal cerebral blood flow in first-episode schizophrenia following treatment: longitudinal positron emission tomography study. Australian and New Zealand Journal of Psychiatry, 41(2), 129–135.
Broome, M. R., Matthiasson, P., Fusar-Poli, P., Woolley, J. B., Johns, L. C., Tabraham, P., et al. (2009). Neural correlates of executive function and working memory in the ‘at-risk mental state’. British Journal of Psychiatry, 194(1), 25–33.
Byrne, M., Hodges, A., Grant, E., Owens, D. G., & Johnstone, E. C. (1999). Neuropsychological assessment of young people at high genetic risk for developing schizophrenia compared with controls: preliminary findings of the Edinburgh High Risk Study (EHRS). Psychological Medicine, 29, 1161–1173.
Cannon, T. D. (2005). Clinical and genetic high-risk strategies in understanding vulnerability to psychosis. Schizophrenia Research, 79(1), 35–44.
Carter, C. S., Perlstein, W., Ganguli, R., Brar, J., Mintun, M., & Cohen, J. D. (1998). Functional hypofrontality and working memory dysfunction in schizophrenia. American Journal of Psychiatry, 155, 1285–1287.
Cornblatt, B. A., & Erlenmeyer-Kimling, L. (1985). Global attentional deviance as a marker of risk for schizophrenia: specificity and predictive validity. Journal of Abnormal Psychology, 94(4), 470–486.
Cornblatt, B. A., & Keilp, J. G. (1994). Impaired attention, genetics, and the pathophysiology of schizophrenia. Schizophrenia Bulletin, 20(1), 31–46.
Cornblatt, B. A., & Malhotra, A. K. (2001). Impaired attention as an endophenotype for molecular genetic studies of schizophrenia. American Journal of Medical Genetics, 105(1), 11–15.
Cosway, R., Byrne, M., Clafferty, R., Hodges, A., Grant, E., Abukmeil, S. S., et al. (2000). Neuropsychological change in young people at high risk for schizophrenia: results from the first two neuropsychological assessments of the Edinburgh High Risk Study. Psychological Medicine, 30(5), 1111–1121.
Cosway, R., Byrne, M., Clafferty, R., Hodges, A., Grant, E., Morris, J., et al. (2002). Sustained attention in young people at high risk for schizophrenia. Psychological Medicine, 32(2), 277–286.
Crossley, N. A., Mechelli, A., Fusar-Poli, P., Broome, M. R., Matthiasson, P., Johns, L. C., et al. (2009). Superior temporal lobe dysfunction and frontotemporal dysconnectivity in subjects at risk of psychosis and in first-episode psychosis. Human Brain Mapping.
Davidson, L. L., & Heinrichs, R. W. (2003). Quantification of frontal and temporal lobe brain-imaging findings in schizophrenia: a meta-analysis. Psychiatry Research, 122(2), 69–87.
De Luca, C. R., Wood, S. J., Anderson, V., Buchanan, J. A., Proffitt, T. M., Mahony, K., et al. (2003). Normative data from the CANTAB. I: development of executive function over the lifespan. Journal of Clinical and Experimental Neuropsychology, 25(2), 242–254.
Dickinson, D., Ramsey, M. E., & Gold, J. M. (2007). Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. Archives of General Psychiatry, 64(5), 532–542.
Eastvold, A. D., Heaton, R. K., and Cadenhead, K. S. (2007). Neurocognitive deficits in the (putative) prodrome and first episode of psychosis. Schizophrenia Research.
Erlenmeyer-Kimling, L., Rock, D., Roberts, S. A., Janal, M., Kestenbaum, C., Cornblatt, B., et al. (2000). Attention, memory, and motor skills as childhood predictors of schizophrenia-related psychoses: the New York high-risk project. American Journal of Psychiatry, 157, 1416–1422.
Ettinger, U., Picchioni, M., Hall, M. H., Schulze, K., Toulopoulou, T., Landau, S., et al. (2006). Antisaccade performance in monozygotic twins discordant for schizophrenia: the Maudsley twin study. American Journal of Psychiatry, 163(3), 543–545.
Feinberg, I. (1982). Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? Journal of Psychiatric Research, 17(4), 319–334.
Fornito, A., Yung, A. R., Wood, S. J., Phillips, L. J., Nelson, B., Cotton, S., et al. (2008). Anatomic abnormalities of the anterior cingulate cortex before psychosis onset: an MRI study of ultra-high-risk individuals. Biological Psychiatry, 64(9), 758–765.
Fornito, A., Yucel, M., Patti, J., Wood, S. J., & Pantelis, C. (2009). Mapping grey matter reductions in schizophrenia: an anatomical likelihood estimation analysis of voxel-based morphometry studies. Schizophrenia Research, 108(1–3), 104–113.
Francey, S. M., Jackson, H. J., Phillips, L. J., Wood, S. J., Yung, A. R., & McGorry, P. D. (2005). Sustained attention in young people at high risk of psychosis does not predict transition to psychosis. Schizophrenia Research, 79(1), 127–136.
Fusar-Poli, P., Broome, M. R., Matthiasson, P., Williams, S. C., Brammer, M., & McGuire, P. K. (2007a). Effects of acute antipsychotic treatment on brain activation in first episode psychosis: an fMRI study. European Neuropsychopharmacology, 17(6–7), 492–500.
Fusar-Poli, P., Perez, J., Broome, M., Borgwardt, S., Placentino, A., Caverzasi, E., et al. (2007b). Neurofunctional correlates of vulnerability to psychosis: a systematic review and meta-analysis. Neuroscience and Biobehavioral Reviews.
Garner, B., Pariante, C. M., Wood, S. J., Velakoulis, D., Phillips, L., Soulsby, B., et al. (2005). Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis. Biological Psychiatry, 58(5), 417–423.
Giedd, J. N. (2004). Structural magnetic resonance imaging of the adolescent brain. Annals of the New York Academy of Sciences, 1021, 77–85.
Glahn, D. C., Thompson, P. M., & Blangero, J. (2007). Neuroimaging endophenotypes: strategies for finding genes influencing brain structure and function. Human Brain Mapping, 28(6), 488–501.
Goghari, V. M., Rehm, K., Carter, C. S., & MacDonald, A. W. (2007a). Sulcal thickness as a vulnerability indicator for schizophrenia. British Journal of Psychiatry, 191, 229–233.
Goghari, V. M., Rehm, K., Carter, C. S., & MacDonald, A. W., 3rd. (2007b). Regionally specific cortical thinning and gray matter abnormalities in the healthy relatives of schizophrenia patients. Cerebral Cortex, 17(2), 415–424.
Gogtay, N., Giedd, J. N., Lusk, L., Hayashi, K. M., Greenstein, D., Vaituzis, A. C., et al. (2004). Dynamic mapping of human cortical development during childhood through early adulthood. Proceedings of the National Academy of Sciences of the United States of America, 101(21), 8174–8179.
Gottesman, I. I., & Gould, T. D. (2003). The endophenotype concept in psychiatry: etymology and strategic intentions. American Journal of Psychiatry, 160(4), 636–645.
Harris, J. M., Moorhead, T. W., Miller, P., McIntosh, A. M., Bonnici, H. M., Owens, D. G., et al. (2007). Increased prefrontal gyrification in a large high-risk cohort characterizes those who develop schizophrenia and reflects abnormal prefrontal development. Biological Psychiatry, 62(7), 722–729.
Harrison, P. J., & Lewis, D. A. (2003). Neuropathology of schizophrenia. In S. R. Hirsch & D. R. Weinberger (Eds.), Schizophrenia (pp. 310–325). Oxford: Blackwell Science.
Hawkins, K. A., Keefe, R. S., Christensen, B. K., Addington, J., Woods, S. W., Callahan, J., et al. (2008). Neuropsychological course in the prodrome and first episode of psychosis: findings from the PRIME North America double blind treatment study. Schizophrenia Research, 105(1–3), 1–9.
Heckers, S. (2001). Neuroimaging studies of the hippocampus in schizophrenia. Hippocampus, 11(5), 520–528.
Hurlemann, R., Jessen, F., Wagner, M., Frommann, I., Ruhrmann, S., Brockhaus, A., et al. (2008). Interrelated neuropsychological and anatomical evidence of hippocampal pathology in the at-risk mental state. Psychological Medicine, 38(6), 843–851.
Huttenlocher, P. (1984). Synapse elimination and plasticity in developing human cerebral cortex. American Journal of Mental Deficiency, 88, 488–496.
Jessen, F., Scherk, H., Träber, F., Theyson, S., Berning, J., Tepest, R., et al. (2006). Proton magnetic resonance spectroscopy in subjects at risk for schizophrenia. Schizophrenia Research, 87, 81–88.
Job, D. E., Whalley, H. C., Johnstone, E. C., & Lawrie, S. M. (2005). Grey matter changes over time in high risk subjects developing schizophrenia. Neuroimage, 25(4), 1023–1030.
Jones, H. M., Brammer, M. J., O’Toole, M., Taylor, T., Ohlsen, R. I., Brown, R. G., et al. (2004). Cortical effects of quetiapine in first-episode schizophrenia: a preliminary functional magnetic resonance imaging study. Biological Psychiatry, 56(12), 938–942.
Keefe, R. S., Perkins, D. O., Gu, H., Zipursky, R. B., Christensen, B. K., & Lieberman, J. A. (2006). A longitudinal study of neurocognitive function in individuals at-risk for psychosis. Schizophrenia Research, 88(1–3), 26–35.
Keshavan, M. S., Berger, G., Zipursky, R. B., Wood, S. J., & Pantelis, C. (2005). Neurobiology of early psychosis. British Journal of Psychiatry. Supplement, 48, s8–s18.
Keshavan, M. S., Prasad, K. M., & Pearlson, G. (2007). Are brain structural abnormalities useful as endophenotypes in schizophrenia? International Review of Psychiatry, 19(4), 397–406.
Klosterkötter, J., Hellmich, M., Steinmeyer, E. M., & Schultze-Lutter, F. (2001). Diagnosing schizophrenia in the initial prodromal phase. Archives of General Psychiatry, 58, 158–164.
Lawrie, S. M., & Abukmeil, S. S. (1998). Brain abnormality in schizophrenia: a systematic and quantitative review of volumetric magnetic resonance imaging studies. British Journal of Psychiatry, 172, 110–120.
Lawrie, S. M., Whalley, H., Kestelman, J. N., Abukmeil, S. S., Byrne, M., Hodges, A., et al. (1999). Magnetic resonance imaging of brain in people at high risk of developing schizophrenia. Lancet, 353, 30–33.
Lawrie, S. M., McIntosh, A. M., Hall, J., Owens, D. G., & Johnstone, E. C. (2008). Brain structure and function changes during the development of schizophrenia: the evidence from studies of subjects at increased genetic risk. Schizophrenia Bulletin, 34(2), 330–340.
Lencz, T., Smith, C. W., McLaughlin, D., Auther, A., Nakayama, E., Hovey, L., et al. (2006). Generalized and specific neurocognitive deficits in prodromal schizophrenia. Biological Psychiatry, 59(9), 863–871.
Luna, B., & Sweeney, J. A. (2001). Studies of brain and cognitive maturation through childhood and adolescence: a strategy for testing neurodevelopmental hypotheses. Schizophrenia Bulletin, 27(3), 443–455.
Luna, B., & Sweeney, J. A. (2004). The emergence of collaborative brain function: FMRI studies of the development of response inhibition. Annals of the New York Academy of Sciences, 1021, 296–309.
Miller, B. L., Chang, L., Booth, R., Ernst, T., Cornford, M., Nikas, D., et al. (1996). In vivo 1H MRS choline: Correlation with in vitro chemistry/histology. Life Sciences, 58(22), 1929–1935.
Mirsky, A. F. (1995). Israeli high risk study: editor’s introduction. Schizophrenia Bulletin, 21(2), 179–182.
Morey, R. A., Inan, S., Mitchell, T. V., Perkins, D. O., Lieberman, J. A., & Belger, A. (2005). Imaging frontostriatal function in ultra-high-risk, early, and chronic schizophrenia during executive processing. Archives of General Psychiatry, 62(3), 254–262.
Murray, R. M., & Lewis, S. W. (1987). Is schizophrenia a neurodevelopmental disorder? [editorial]. Br Med J (Clin Res Ed), 295(6600), 681–682.
Murray, G. K., Jones, P. B., Kuh, D., & Richards, M. (2007). Infant developmental milestones and subsequent cognitive function. Annals of Neurology, 62(2), 128–136.
Nakamura, M., Salisbury, D. F., Hirayasu, Y., Bouix, S., Pohl, K. M., Yoshida, T., et al. (2007). Neocortical gray matter volume in first-episode schizophrenia and first-episode affective psychosis: a cross-sectional and longitudinal MRI study. Biological Psychiatry, 62(7), 773–783.
Nelson, M. D., Saykin, A. J., Flashman, L. A., & Riordan, H. J. (1998). Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study. Archives of General Psychiatry, 55, 433–440.
Nieman, D., Becker, H., van de Fliert, R., Plat, N., Bour, L., Koelman, H., et al. (2007). Antisaccade task performance in patients at ultra high risk for developing psychosis. Schizophrenia Research, 95(1–3), 54–60.
Olsen, K. A., & Rosenbaum, B. (2006). Prospective investigations of the prodromal state of schizophrenia: review of studies. Acta Psychiatrica Scandinavica, 113(4), 247–272.
Pantelis, C., & Wood, S. J. (2009). Imaging in Schizophrenia: looking back and peering ahead. Annals of the Academy of Medicine, Singapore, 38(5), 440–441.
Pantelis, C., Velakoulis, D., McGorry, P. D., Wood, S. J., Suckling, J., Phillips, L. J., et al. (2003). Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet, 361(9354), 281–288.
Pantelis, C., Yucel, M., Wood, S. J., Velakoulis, D., Sun, D., Berger, G., et al. (2005). Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophrenia Bulletin, 31(3), 672–696.
Pantelis, C., Velakoulis, D., Wood, S. J., Yucel, M., Yung, A. R., Phillips, L. J., et al. (2007). Neuroimaging and emerging psychotic disorders: the Melbourne ultra-high risk studies. International Review of Psychiatry, 19(4), 371–379.
Pantelis, C., Yücel, M., Wood, S. J., Brewer, W. J., Fornito, A., Berger, G., et al. (2009). Neurobiological endophenotypes of psychosis and schizophrenia: Are there biological markers of illness onset? In H. J. Jackson & P. D. McGorry (Eds.), The recognition and management of early psychosis: A preventive approach (pp. 61–80). Cambridge: Cambridge University Press.
Paus, T. (2005). Mapping brain maturation and cognitive development during adolescence. Trends in Cognitive Sciences, 9(2), 60–68.
Phillips, L. J., Velakoulis, D., Pantelis, C., Wood, S., Yuen, H. P., Yung, A. R., et al. (2002). Non-reduction in hippocampal volume is associated with higher risk of psychosis. Schizophrenia Research, 58(2–3), 145–158.
Pukrop, R., Schultze-Lutter, F., Ruhrmann, S., Brockhaus-Dumke, A., Tendolkar, I., Bechdolf, A., et al. (2006). Neurocognitive functioning in subjects at risk for a first episode of psychosis compared with first- and multiple-episode schizophrenia. Journal of Clinical and Experimental Neuropsychology, 28(8), 1388–1407.
Pukrop, R., Ruhrmann, S., Schultze-Lutter, F., Bechdolf, A., Brockhaus-Dumke, A., & Klosterkotter, J. (2007). Neurocognitive indicators for a conversion to psychosis: comparison of patients in a potentially initial prodromal state who did or did not convert to a psychosis. Schizophrenia Research, 92(1–3), 116–125.
Reddy, R., & Keshavan, M. S. (2003). Phosphorus magnetic resonance spectroscopy: its utility in examining the membrane hypothesis of schizophrenia. Prostaglandins Leukotrienes and Essential Fatty Acids, 69(6), 401–405.
Rutschmann, J., Cornblatt, B., & Erlenmeyer-Kimling, L. (1977). Sustained attention in children at risk for schizophrenia. Report on a continuous performance test. Archives of General Psychiatry, 34(5), 571–575.
Schall, U., Halpin, S. A., Hunt, S. A., Beckmann, J., Chenoweth, B., Mah, B. L., et al. (2003). Neurocognitive profiles of young people at high risk versus first-episode psychosis: a follow-up study. Schizophrenia Research, 60(Suppl), 156.
Schultze-Lutter, F., Ruhrmann, S., Picker, H., von Reventlow, H. G., Daumann, B., Brockhaus-Dumke, A., et al. (2007). Relationship between subjective and objective cognitive function in the early and late prodrome. British Journal of Psychiatry. Supplement, 51, s43–s51.
Seiferth, N. Y., Pauly, K., Habel, U., Kellermann, T., Shah, N. J., Ruhrmann, S., et al. (2008). Increased neural response related to neutral faces in individuals at risk for psychosis. Neuroimage, 40(1), 289–297.
Simon, A. E., Cattapan-Ludewig, K., Zmilacher, S., Arbach, D., Gruber, K., Dvorsky, D. N., et al. (2007). Cognitive functioning in the schizophrenia prodrome. Schizophrenia Bulletin, 33(3), 761–771.
Smyrnis, N., Evdokimidis, I., Stefanis, N. C., Avramopoulos, D., Constantinidis, T. S., Stavropoulos, A., et al. (2003). Antisaccade performance of 1, 273 men: effects of schizotypy, anxiety, and depression. Journal of Abnormal Psychology, 112(3), 403–414.
Snitz, B. E., MacDonald, A., 3rd, Cohen, J. D., Cho, R. Y., Becker, T., & Carter, C. S. (2005). Lateral and medial hypofrontality in first-episode schizophrenia: functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment. American Journal of Psychiatry, 162(12), 2322–2329.
Steen, R. G., Mull, C., McClure, R., Hamer, R. M., & Lieberman, J. A. (2006). Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. British Journal of Psychiatry, 188, 510–518.
Sun, D., Stuart, G. W., Jenkinson, M., Wood, S. J., McGorry, P. D., Velakoulis, D., van Erp, T. G., Thompson, P. M., Toga, A. W., Smith, D. J., Cannon, T. D., and Pantelis, C. (2008). Brain surface contraction mapped in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Molecular Psychiatry.
Sun, D., Phillips, L., Velakoulis, D., Yung, A., McGorry, P. D., Wood, S. J., et al. (2009). Progressive brain structural changes mapped as psychosis develops in ‘at risk’ individuals. Schizophrenia Research, 108(1–3), 85–92.
Swerdlow, N. R., Light, G. A., Cadenhead, K. S., Sprock, J., Hsieh, M. H., & Braff, D. L. (2006). Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function. Archives of General Psychiatry, 63(12), 1325–1335.
Taanila, A., Murray, G. K., Jokelainen, J., Isohanni, M., & Rantakallio, P. (2005). Infant developmental milestones: a 31-year follow-up. Developmental Medicine and Child Neurology, 47(9), 581–586.
Testa, R., & Pantelis, C. (2009). The role of executive functions in psychiatric disorders. In S. J. Wood, N. Allen & C. Pantelis (Eds.), The neuropsychology of mental illness. Cambridge: Cambridge University Press. Vol. in press.
Thompson, P. M., Woods, R. P., Mega, M. S., & Toga, A. W. (2000). Mathematical/computational challenges in creating deformable and probabilistic atlases of the human brain. Human Brain Mapping, 9(2), 81–92.
Turetsky, B. I., Calkins, M. E., Light, G. A., Olincy, A., Radant, A. D., & Swerdlow, N. R. (2007). Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. Schizophrenia Bulletin, 33(1), 69–94.
Velakoulis, D., & Pantelis, C. (1996). What have we learned from functional imaging studies in schizophrenia? The role of frontal, striatal and temporal areas. Australian and New Zealand Journal of Psychiatry, 30, 195–209.
Velakoulis, D., Wood, S. J., Wong, M. T., McGorry, P. D., Yung, A., Phillips, L., et al. (2006). Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Archives of General Psychiatry, 63(2), 139–149.
Weinberger, D. R. (1987). Implications of normal brain development for the pathogenesis of schizophrenia. Archives of General Psychiatry, 44, 660–669.
Weinberger, D. R. (2002). Biological phenotypes and genetic research on schizophrenia. World Psychiatry, 1(1), 2–6.
Weintraub, S. (1987). Risk factors in schizophrenia: the stony brook high-risk project. Schizophrenia Bulletin, 13(3), 439–450.
Whalley, H. C., Simonotto, E., Moorhead, W., McIntosh, A., Marshall, I., Ebmeier, K. P., et al. (2006). Functional imaging as a predictor of schizophrenia. Biological Psychiatry, 60(5), 454–462.
Whalley, H. C., Harris, J. C., & Lawrie, S. M. (2007). The neurobiological underpinnings of risk and conversion in relatives of patients with schizophrenia. International Review of Psychiatry, 19(4), 383–397.
Whyte, M. C., Brett, C., Harrison, L. K., Byrne, M., Miller, P., Lawrie, S. M., et al. (2006). Neuropsychological performance over time in people at high risk of developing schizophrenia and controls. Biological Psychiatry, 59(8), 730–739.
Wolf, L. E., Cornblatt, B. A., Roberts, S. A., Shapiro, B. M., & Erlenmeyer-Kimling, L. (2002). Wisconsin Card Sorting deficits in the offspring of schizophrenics in the New York High-Risk Project. Schizophrenia Research, 57(2–3), 173.
Wood, S. J., Berger, G., Velakoulis, D., Phillips, L. J., McGorry, P. D., Yung, A. R., et al. (2003a). Proton magnetic resonance spectroscopy in first episode psychosis and ultra high-risk individuals. Schizophrenia Bulletin, 29(4), 831–843.
Wood, S. J., Pantelis, C., Proffitt, T., Phillips, L. J., Stuart, G. W., Buchanan, J. A., et al. (2003b). Spatial working memory ability is a marker of risk-for-psychosis. Psychological Medicine, 33(7), 1239–1247.
Wood, S. J., De Luca, C. R., Anderson, V., & Pantelis, C. (2004). Cognitive development in adolescence: Cerebral underpinnings, neural trajectories and the impact of aberrations. In M. S. Keshavan, J. L. Kennedy & R. M. Murray (Eds.), Neurodevelopment and schizophrenia (pp. 69–88). Cambridge: Cambridge University Press.
Wood, S. J., Yucel, M., Velakoulis, D., Phillips, L. J., Yung, A. R., Brewer, W., et al. (2005). Hippocampal and anterior cingulate morphology in subjects at ultra-high-risk for psychosis: the role of family history of psychotic illness. Schizophrenia Research, 75(2–3), 295–301.
Wood, S. J., Brewer, W. J., Koutsouradis, P., Phillips, L. J., Francey, S. M., Proffitt, T. M., et al. (2007). Cognitive decline following psychosis onset: data from the PACE clinic. British Journal of Psychiatry. Supplement, 51, s52–s57.
Wood, S. J., Pantelis, C., Velakoulis, D., Yücel, M., Fornito, A., & McGorry, P. D. (2008). Progressive changes in the development towards schizophrenia: studies in subjects at increased symptomatic risk. Schizophrenia Bulletin, 34(2), 322–329.
Wood, S. J., Pantelis, C., Yung, A. R., Velakoulis, D., & McGorry, P. D. (2009). Brain changes during the onset of schizophrenia: implications for neurodevelopmental theories. Medical Journal of Australia, 190(4), S10–S13.
Woods, B. T., Ward, K. E., & Johnson, E. H. (2005). Meta-analysis of the time-course of brain volume reduction in schizophrenia: implications for pathogenesis and early treatment. Schizophrenia Research, 73(2–3), 221–228.
Wright, I. C., Rabe-Hesketh, S., Woodruff, P. W., David, A. S., Murray, R. M., & Bullmore, E. T. (2000). Meta-analysis of regional brain volumes in schizophrenia. American Journal of Psychiatry, 157(1), 16–25.
Yücel, M., Stuart, G. W., Maruff, P., Velakoulis, D., Crowe, S. F., Savage, G., et al. (2001). Hemispheric and gender-related differences in the gross morphology of the anterior cingulate/paracingulate cortex in normal volunteers: an MRI morphometric study. Cerebral Cortex, 11, 17–25.
Yücel, M., Stuart, G. W., Maruff, P., Wood, S., Savage, G., Smith, D. J., et al. (2002). Paracingulate morphological differences in males with established schizophrenia: a magnetic resonance imaging morphometric study. Biological Psychiatry, 52(1), 15–23.
Yücel, M., Wood, S. J., Phillips, L. J., Stuart, G. W., Smith, D. J., Yung, A., et al. (2003). Morphology of the anterior cingulate cortex in young men at ultra-high risk of developing a psychotic illness. British Journal of Psychiatry, 182, 518–524.
Yung, A. R., Stanford, C., Cosgrave, E., Killackey, E., Phillips, L., Nelson, B., et al. (2006). Testing the ultra high risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people. Schizophrenia Research, 84(1), 57–66.
Acknowledgements
This work was supported by project grants from the National Health & Medical Research Council (NHMRC; grant IDs: 145627, 145737, 236175, 970598, 981112, 970391), NHMRC Program Grants (ID: 350241, 566529). Drs. Yücel, Wood, Brewer and Fornito are supported by fellowships from NHMRC (IDs: 509345, 359223, 454792, 454797, respectively). Dr. Wood is also supported by a NARSAD Young Investigator Award.
Disclosures
The authors have no conflicts to disclose with respect to the content or writing of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pantelis, C., Yücel, M., Bora, E. et al. Neurobiological Markers of Illness Onset in Psychosis and Schizophrenia: The Search for a Moving Target. Neuropsychol Rev 19, 385–398 (2009). https://doi.org/10.1007/s11065-009-9114-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11065-009-9114-1